| DACRA induces profound weight loss, satiety control, and increased mitochondrial respiratory capacity in adipose tissue EA Petersen, I Blom, SA Melander, M Al-Rubai, M Vidotto, LT Dalgaard, ... International Journal of Obesity, 1-9, 2024 | | 2024 |
| The enduring metabolic improvement of combining dual amylin and calcitonin receptor agonist and semaglutide treatments in a rat model of obesity and diabetes AT Larsen, KE Mohamed, SA Melander, MA Karsdal, K Henriksen American Journal of Physiology-Endocrinology and Metabolism, 2024 | | 2024 |
| Are insulin sensitizers the new strategy to treat Type 1 diabetes? A long‐acting dual amylin and calcitonin receptor agonist improves insulin‐mediated glycaemic control and … SA Melander, AT Larsen, MA Karsdal, K Henriksen British Journal of Pharmacology 181 (12), 1829-1842, 2024 | 1 | 2024 |
| Endotrophin, a Key Marker and Driver for Fibroinflammatory Disease K Henriksen, F Genovese, A Reese-Petersen, LP Audoly, K Sun, ... Endocrine reviews 45 (3), 361-378, 2024 | 1 | 2024 |
| Serum Tau-A and Tau-C Levels and Their Association with Cognitive Impairment and Dementia Progression in a Memory Clinic Derived Cohort TM Axelsen, P Høgh, AR Bihlet, MA Karsdal, K Henriksen, ... The Journal of Prevention of Alzheimer's Disease 11 (3), 730-738, 2024 | | 2024 |
| The Insulin Sensitizer KBP-336 Prevents Diabetes-Induced Cognitive decline in ZDF Rats AT Larsen, KE Mohamed, EA Petersen, MA Karsdal, K Henriksen The Journal of Prevention of Alzheimer's Disease, 1-10, 2024 | | 2024 |
| Weight loss lead to significant effects on OA pain and function: Do the benefits outweigh the risks? AC Bay-Jensen, K Muhamed, AR Bihlet, CS Thudium, K Henriksen, ... Osteoarthritis and Cartilage 32, S499-S500, 2024 | | 2024 |
| OXM-104, a potential candidate for the treatment of obesity, NASH and type 2 diabetes SA Melander, A Kayed, KV Andreassen, MA Karsdal, K Henriksen European Journal of Pharmacology 962, 176215, 2024 | 2 | 2024 |
| Collagen diseases SH Nielsen, S Sardar, MA Karsdal, K Henriksen Biochemistry of Collagens, Laminins and Elastin, 371-398, 2024 | | 2024 |
| Type I collagen K Henriksen, MA Karsdal Biochemistry of collagens, laminins and elastin, 1-11, 2024 | 152 | 2024 |
| Dual amylin and calcitonin receptor agonist treatment reduces biomarkers associated with kidney fibrosis in diabetic rats SA Melander, AL Møller, KE Mohamed, DGK Rasmussen, F Genovese, ... American Journal of Physiology-Endocrinology and Metabolism 325 (5), E529-E539, 2023 | 1 | 2023 |
| Treatment sequencing using the dual amylin and calcitonin receptor agonist KBP-336 and semaglutide results in durable weight loss AT Larsen, MA Karsdal, K Henriksen European Journal of Pharmacology 954, 175837, 2023 | 4 | 2023 |
| A genetic validation of the neurodegeneration biomarkers tau-A and tau-C-a Mendelian randomization study TM Axelsen, C Bager, A Bihlet, MA Karsdal, K Henriksen, MHE Tang The Journal of Prevention of Alzheimer's Disease 10 (3), 536-542, 2023 | 3 | 2023 |
| Dual amylin and calcitonin receptor agonist treatment improves insulin sensitivity and increases muscle-specific glucose uptake independent of weight loss AT Larsen, SA Melander, N Sonne, E Bredtoft, M Al-Rubai, MA Karsdal, ... Biomedicine & Pharmacotherapy 164, 114969, 2023 | 5 | 2023 |
| 426-P: Semaglutide, Empagliflozin, and Cagrilintide Reduce Levels of Serum Endotrophin in Type 2 Diabetic Rats A MØLLER, SA MELANDER, AT LARSEN, CFG LAURSEN, ... Diabetes 72 (Supplement_1), 2023 | | 2023 |
| 211-OR: Dual Amylin and Calcitonin Receptor Agonists Increase Mitochondrial Respiratory Capacity in Adipose Tissues of Obese Rat EA PETERSEN, IDA BLOM, SA MELANDER, MA KARSDAL, S LARSEN, ... Diabetes 72 (Supplement_1), 2023 | | 2023 |
| 840-P: Dual Amylin and Calcitonin Receptor Agonist Treatment Improves Blood Pressure and Glucose Control in ZSF1 Rats SA MELANDER, AT LARSEN, K ELHADY MOHAMED, MA KARSDAL, ... Diabetes 72 (Supplement_1), 2023 | | 2023 |
| 861-P: The Effect of Dual Amylin and Calcitonin Receptor Agonist Treatment on Spatial Memory in Rat Models of Metabolic Syndrome K ELHADY MOHAMED, AT LARSEN, SA MELANDER, MA KARSDAL, ... Diabetes 72 (Supplement_1), 2023 | | 2023 |
| Evaluation of Rodent PRO-C6, a Biomarker of Type VI Collagen Formation, in a Bleomycin Induced IPF Mouse Model M Skarsfeldt, S Jansen, A Møller, M Karsdal, K Henriksen, DJ Leeming, ... A67. BIOMARKERS, MEDIATORS, AND TRANSLATIONAL MODELS FOR ILD, A2255-A2255, 2023 | | 2023 |
| Immunoassay for collagen type VI A Nedergaard, JM Sand, S Sun, DJ Oersnes-Leeming, K Henriksen US Patent 11,634,479, 2023 | | 2023 |
